Yunnan Completed Pilot Platform for Natural Drugs    

Yunnan Institute of Materia Medica recently announced it completed construction of a platform for natural drugs at the biopharmaceutical pilot center of Kunming Biological Industry Base, with a total investment of RMB44 million.
   The platform is capable of doing pilot test for various formats of natural drugs.